Am. J. Respir. Crit. Care Med., Volume 162, Number 3, September 2000, 789-794

Bone Density, Body Composition, and Inflammatory Status in Cystic Fibrosis

ALINA A. IONESCU, LISETTE S. NIXON, WILLIAM D. EVANS, MICHAEL D. STONE, VANESSA LEWIS-JENKINS, KEN CHATHAM, and DENNIS J. SHALE

Section of Respiratory Medicine, University of Wales College of Medicine and the Bone Research Unit, Academic Centre, University Hospital of Wales and Llandough Hospital NHS Trust, Penarth, South Glamorgan, United Kingdom; and Department of Medical Physics and Clinical Engineering, University Hospital of Wales and Llandough Hospital NHS Trust, Heath Park, Cardiff, United Kingdom

Low body weight and loss of bone mass are major problems in adults with cystic fibrosis (CF) and chronic pulmonary infection. Although these complications probably have a multifactorial origin, we hypothesized that the continuous acute-phase inflammatory and catabolic state may contribute. We determined body composition, bone turnover, physical activity, and circulating interleukin-6 (IL-6), tumor necrosis factor- (TNF-), and their soluble receptors in 22 adults with CF and 22 age- and sex-matched healthy subjects. Comparisons were also made within patients before and after treatment of an exacerbation of respiratory symptoms. The patients had a lower mean (95% confidence interval [CI]) fat-free mass (FFM) 39.9 (36.3, 43.6) kg than healthy subjects, 49.4 (45.1, 53.7) kg, p < 0.05. The patients were in negative nitrogen balance and 20 had bone mineral density (BMD) Z scores  2.5 SD (n = 13) or  1 SD (n = 7) at least at one site. They had increased bone collagen breakdown, greatest in those with a reduced FFM. BMD was related to FEV₁ (r = 0.44), IL-6 (r = 0.60), and TNF--soluble receptors (r = 0.42, r = 0.50). Patients with a low FFM had greater concentrations of IL-6, which suppressed less after antibiotic treatment than in those with a normal FFM. Those with a low FFM were more catabolic and less active than those with a normal FFM. The association between altered body composition, catabolic status, and circulating inflammatory mediators suggests that chronic pulmonary infection in adults with CF may be a contributory factor in the long-term complications of low weight and bone disease.

This article has been cited by other articles:

				I. Sermet-Gaudelus, J. C. Souberbielle, J. C. Ruiz, S. Vrielynck, B. Heuillon, I. Azhar, A. Cazenave, E. Lawson-Body, F. Chedevergne, and G. Lenoir Low Bone Mineral Density in Young Children with Cystic Fibrosis Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 951 - 957. [Abstract] [Full Text] [PDF]

				E. F. Shead, C. S. Haworth, E. Gunn, D. Bilton, M. A. Scott, and J. E. Compston Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 306 - 311. [Abstract] [Full Text] [PDF]

				N. Moriconi, M. Kraenzlin, B. Muller, U. Keller, C. P. G. Nusbaumer, S. Stohr, M. Tamm, and J. J. Puder Body Composition and Adiponectin Serum Concentrations in Adult Patients with Cystic Fibrosis J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1586 - 1590. [Abstract] [Full Text] [PDF]

				N. M. Maalouf and E. Shane Osteoporosis after Solid Organ Transplantation J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2456 - 2465. [Abstract] [Full Text] [PDF]

				K. Cormier, D. Mager, L. Bannister, M. Fortin, H. Richards, C. Jackson, and P. Pencharz Resting Energy Expenditure in the Parenterally Fed Pediatric Population With Crohn's Disease JPEN J Parenter Enteral Nutr, March 1, 2005; 29(2): 102 - 107. [Abstract] [Full Text] [PDF]

				S. J. King, D. J. Topliss, T. Kotsimbos, I. B. Nyulasi, M. Bailey, P. R. Ebeling, and J. W. Wilson Reduced bone density in cystic fibrosis: {Delta}F508 mutation is an independent risk factor Eur. Respir. J., January 1, 2005; 25(1): 54 - 61. [Abstract] [Full Text] [PDF]

				A. M. Taveira-DaSilva, M. P. Stylianou, C. J. Hedin, O. Hathaway, and J. Moss Bone Mineral Density in Lymphangioleiomyomatosis Am. J. Respir. Crit. Care Med., January 1, 2005; 171(1): 61 - 67. [Abstract] [Full Text] [PDF]

				S P Conway, B Oldroyd, A Morton, J G Truscott, and D G Peckham Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study Thorax, August 1, 2004; 59(8): 699 - 703. [Abstract] [Full Text] [PDF]

				E. Gronowitz, D. Mellstrom, and B. Strandvik Normal Annual Increase of Bone Mineral Density During Two Years in Patients With Cystic Fibrosis Pediatrics, August 1, 2004; 114(2): 435 - 442. [Abstract] [Full Text] [PDF]

				C S Haworth, P L Selby, A K Webb, L Martin, J S Elborn, L D Sharples, and J E Adams Inflammatory related changes in bone mineral content in adults with cystic fibrosis Thorax, July 1, 2004; 59(7): 613 - 617. [Abstract] [Full Text] [PDF]

				O. Gluck and G. Colice Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases Chest, May 1, 2004; 125(5): 1859 - 1876. [Abstract] [Full Text] [PDF]

				A. A. Ionescu, W. D. Evans, R. J. Pettit, L. S. Nixon, M. D. Stone, and D. J. Shale Hidden Depletion of Fat-Free Mass and Bone Mineral Density in Adults With Cystic Fibrosis Chest, December 1, 2003; 124(6): 2220 - 2228. [Abstract] [Full Text] [PDF]

				A.A. Ionescu and E. Schoon Osteoporosis in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 64s - 75s. [Abstract] [Full Text] [PDF]

				I Sermet-Gaudelus, J C Souberbielle, I Azhar, J C Ruiz, P Magnine, V Colomb, C Le Bihan, D Folio, and G Lenoir Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients Arch. Dis. Child., November 1, 2003; 88(11): 956 - 961. [Abstract] [Full Text] [PDF]

				F. Maltais Skeletal Muscles in Chronic Airflow Obstruction: Why Bother? Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 916 - 917. [Full Text] [PDF]

				C E Bolton, A A Ionescu, W D Evans, R J Pettit, and D J Shale Altered tissue distribution in adults with cystic fibrosis Thorax, October 1, 2003; 58(10): 885 - 889. [Abstract] [Full Text] [PDF]

				R. Debigare, K. Marquis, C. H. Cote, R. R. Tremblay, A. Michaud, P. LeBlanc, and F. Maltais Catabolic/Anabolic Balance and Muscle Wasting in Patients With COPD Chest, July 1, 2003; 124(1): 83 - 89. [Abstract] [Full Text] [PDF]

				K. Marquis, R. Debigare, Y. Lacasse, P. LeBlanc, J. Jobin, G. Carrier, and F. Maltais Midthigh Muscle Cross-Sectional Area Is a Better Predictor of Mortality than Body Mass Index in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 809 - 813. [Abstract] [Full Text]

				C S Haworth, P L Selby, A W Horrocks, E B Mawer, J E Adams, and A K Webb A prospective study of change in bone mineral density over one year in adults with cystic fibrosis Thorax, August 1, 2002; 57(8): 719 - 723. [Abstract] [Full Text] [PDF]

				A. A. IONESCU, L. S. NIXON, S. LUZIO, V. LEWIS-JENKINS, W. D. EVANS, M. D. STONE, D. R. OWENS, P. A. ROUTLEDGE, and D. J. SHALE Pulmonary Function, Body Composition, and Protein Catabolism in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 495 - 500. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1581 - 1594. [Full Text] [PDF]

				A. A. IONESCU, A.-A. IONESCU, N. PAYNE, I. OBIETA-FRESNEDO, A. G. FRASER, and D. J. SHALE Subclinical Right Ventricular Dysfunction in Cystic Fibrosis . A Study Using Tissue Doppler Echocardiography Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1212 - 1218. [Abstract] [Full Text]

				K. Wallick, J. A. Nick, and D. M. Rodman Cystic Fibrosis Critical Care . No Longer an Oxymoron Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 310 - 312. [Full Text]